亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

山東鉑源制藥有限公司  

沒(méi)有填寫主營(yíng)業(yè)務(wù)~~

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
  • 暫無(wú)分類
聯(lián)系方式
  • 聯(lián)系人:于恒利
  • 電話:0133-35113848
  • QQ:2283440920
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
首頁(yè) > 供應(yīng)產(chǎn)品 > 苯磺酸阿曲庫(kù)銨
苯磺酸阿曲庫(kù)銨
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 山東濟(jì)南市付款后3天內(nèi)
型號(hào) 64228-81-5
過(guò)期 長(zhǎng)期有效
更新 2013-01-05 16:15
 
詳細(xì)信息

苯磺酸阿曲庫(kù)銨
CAS NO.:64228-81-5
英文名:Atracurium Besylate
別名:苯磺安托肌松、苯磺阿曲庫(kù)銨、2,2'-[1,5-戊二基雙[氧(3-氧-3,1-丙二基)]]雙[1-(3,4-二甲氧基苯基)甲基]-1,2,3,4-四氫-6,7-二甲氧基-2-甲基異喹啉]二苯磺酸鹽
分子式:C53H72N2O12·2(C6H5O3S)
分子量:1243.48 
標(biāo)準(zhǔn):EP5.2, USP30
用途:麻醉用藥物
©2025 山東鉑源制藥有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問(wèn)量:5818  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |